William Edward Louch

William Edward Louch

Auto-generated profile, based on publicly available information

William Edward Louch

Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
WLWilliam E. Louch
William E. Louch
KSKatherine A. Sheehan
Katherine A. Sheehan
BWBeata M Wolska
Beata M Wolska

6 July 2006 in The Journal of Physiology
Verified
Journal Article
Closed access
WLWilliam E. Louch
William E. Louch
HMHalvor K. Mørk
Halvor K. Mørk
JSJoseph Sexton
Joseph Sexton
TSTævje A. Strømme
Tævje A. Strømme
PLPetter Laake
Petter Laake
OSOle M. Sejersted
Ole M. Sejersted

30 October 2018 in eLife
Verified
Journal Article
Open access
TKTerje R Kolstad
Terje R Kolstad
JBJonas van Den Brink
Jonas van Den Brink
NMNiall MacQuaide
Niall MacQuaide
PLPer Kristian Lunde
Per Kristian Lunde
MFMichael Frisk
Michael Frisk
WLWilliam E Louch
William E Louch
Reduced cardiac contractility during heart failure (HF) is linked to impaired Ca2+ release from Ryanodine Receptors (RyRs). We investigated whether this deficit can be traced to nanoscale RyR reorganization. Using super-resolution imaging, we observed dispersion of RyR clusters in cardiomyocytes from post-infarction HF rats, resulting in more numerous, smaller clusters. Functional groupings of RyR clusters which produce Ca2+ sparks (Ca2+ release units, CRUs) also became less solid. An increased fraction of small CRUs in HF was linked to augmented ‘silent’ Ca2+ leak, not visible as sparks. Larger multi-cluster CRUs common in HF also exhibited low fidelity spark generation. When successfully triggered, sparks in failing cells displayed slow kinetics as Ca2+ spread across dispersed CRUs. During the action potential, these slow sparks protracted and desynchronized the overall Ca2+ transient. Thus, nanoscale RyR reorganization during HF augments Ca2+ leak and slows Ca2+ release kinetics, leading to weakened contraction in this disease.

29 January 2010 in The Journal of Physiology
Verified
Journal Article
Closed access
WLWilliam E. Louch
William E. Louch
KHKarina Hougen
Karina Hougen
HMHalvor K. Mørk
Halvor K. Mørk
FSFredrik Swift
Fredrik Swift
JAJan M. Aronsen
Jan M. Aronsen
OSOle M. Sejersted
Ole M. Sejersted

3 December 2014 in Current Pharmaceutical Design
Verified
Journal Article
Open access
ARAsmund Roe
Asmund Roe
MFMichael Frisk
Michael Frisk
WLWilliam Louch
William Louch
Improved treatments for heart failure patients will require the development of novel therapeutic strategies that target basal disease mechanisms. Disrupted cardiomyocyte Ca2+ homeostasis is recognized as a major contributor to the heart failure phenotype, as it plays a key role in systolic and diastolic dysfunction, arrhythmogenesis, and hypertrophy and apoptosis signaling. In this review, we outline existing knowledge of the involvement of Ca2+ homeostasis in these deficits, and identify four promising targets for therapeutic intervention: the sarcoplasmic reticulum Ca2+ ATPase, the Na+-Ca2+ exchanger, the ryanodine receptor, and t-tubule structure. We discuss experimental data indicating the applicability of these targets that has led to recent and ongoing clinical trials, and suggest future therapeutic approaches.

8 April 2010 in Journal of Biomedicine and Biotechnology
Verified
Journal Article
Open access
PDF file
WLWilliam E. Louch
William E. Louch
OSOle M. Sejersted
Ole M. Sejersted
FSFredrik Swift
Fredrik Swift
T-tubules are invaginations of the cardiomyocyte membrane into the cell interior which form a tortuous network. T-tubules provide proximity between the electrically excitable cell membrane and the sarcoplasmic reticulum, the main intracellular store. Tight coupling between the rapidly spreading action potential and release units in the SR membrane ensures synchronous release throughout the cardiomyocyte. This is a requirement for rapid and powerful contraction. In recent years, it has become clear that T-tubule structure and composition are altered in several pathological states which may importantly contribute to contractile defects in these conditions. In this review, we describe the “neighborhood” of proteins in the dyadic cleft which locally controls cardiomyocyte homeostasis and how alterations in T-tubule structure and composition may alter this neighborhood during heart failure, atrial fibrillation, and diabetic cardiomyopathy. Based on this evidence, we propose that T-tubules have the potential to serve as novel therapeutic targets.